Related Experiment Videos
Platelet-derived growth factor in human glioma
B Westermark1, C H Heldin, M Nistér
1Department of Pathology, University Hospital, Uppsala, Sweden.
Glia
|November 1, 1995
Summary
Platelet-derived growth factor (PDGF) drives glioma cell proliferation through autocrine receptor activation. Blocking PDGF signaling inhibits glioma growth, indicating its therapeutic potential.
Area of Science:
- Molecular Biology
- Oncology
- Cell Signaling
Background:
- Platelet-derived growth factor (PDGF) is crucial for development.
- PDGF receptors (alpha and beta) are protein-tyrosine kinases.
- The v-sis oncogene induces transformation via autocrine PDGF receptor activation.
Purpose of the Study:
- Investigate the role of autocrine PDGF signaling in glioma development.
- Determine if PDGF antagonists can inhibit glioma cell growth.
Main Methods:
- Analysis of PDGF and PDGF receptor coexpression in human glioma cell lines.
- In situ studies of PDGF alpha-receptor expression in human gliomas.
- Testing the efficacy of PDGF antagonists in vitro and in vivo.
Main Results:
- PDGF and PDGF receptors are coexpressed in human glioma cell lines.
- High-grade gliomas show overexpression of PDGF alpha-receptors, sometimes due to receptor amplification.
- PDGF antagonists block the growth of some glioma cell lines.
Conclusions:
- Autocrine PDGF signaling contributes to glioma transformation and tumorigenesis.
- Overexpression of PDGF alpha-receptors, driven by A-chain expression, may promote glioma cell proliferation.
- Targeting PDGF signaling represents a potential therapeutic strategy for gliomas.